Wanwisa Bumrungpagdee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Wanwisa Bumrungpagdee has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Suppachai Lawanaskol
Chaiprakarn Hospital, Chaiprakarn District, Chiang Mai 50320, Thailand
6 shared publications - Suwapim Chanlaor
Department of Radiology, Buddhachinaraj Phitsanulok Hospital, Phitsanulok 65000, Thailand
6 shared publications - Thanin Lokeskrawee
Department of Emergency Medicine, Lampang Hospital, Mueang District, Lampang 52000, Thailand
6 shared publications - Chawalit Lakdee
Department of Radiology, Buddhachinaraj Phitsanulok Hospital, Phitsanulok 65000, Thailand
5 shared publications Jayanton Patumanond
Clinical Epidemiology and Clinical Statistics Unit, Faculty of Medicine, Naresuan University, Phitsanulok 65000, Thailand
4 shared publications- Natthaphon Pruksathorn
Lampang Hospital
4 shared publications
Latest Publications
- Open Access
- 26 October 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (10) , e0350690
Comparison of three emergency department triage systems among Thai medical students: A randomized three-period crossover simulation study
Introduction: In Thailand, the Emergency Severity Index (ESI) and Ministry of Public Health Emergency Department triage system (MOPH) are commonly used, whereas the Thai Rapid Initial Assessment and Grading for Emergency (TRIAGE) system has been newly proposed. Comparative evidence is limited. We compared correct triage as the primary outcome, with under-triage, over-triage, and completion time as secondary outcomes. Methods: We conducted a randomized three-period crossover simulation study at the Lampang Medical Education Center from October 2025 to January 2026. Fifth- and sixth-year medical students without recent standardized triage reinforcement classified 50 standardized patient cards per system in one of six sequences, with a one-week washout between periods. Multilevel mixed-effects models were used to estimate between-system differences, with adjustment for period, sequence, and academic year. Results: Sixty students completed all periods. No significant overall differences were detected in correct triage across TRIAGE, ESI, and MOPH (63.2%, 64.5%, and 61.8%, respectively), or in under-triage (19.6%, 20.0%, and 18.8%). Among sixth-year students, correct triage differed significantly across systems (global P = 0.004), with higher adjusted probabilities for ESI and TRIAGE than MOPH. Over-triage differed across systems and was highest with MOPH (7.0%), followed by TRIAGE (5.7%) and ESI (4.9%). Completion time was longest with TRIAGE (32.8 minutes), compared with ESI (24.3 minutes) and MOPH (23.2 minutes). Conclusion: No significant overall differences in correct or under-triage were detected, but the study was not powered to establish equivalence. MOPH showed higher over-triage, Completion time was longest with TRIAGE. Generalizability to experienced clinicians requires further study. Trial registration: Thai Clinical Trials Registry (TCTR) TCTR20260316003
- 26 October 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (10) , e0350690
Open AccessComparison of three emergency department triage systems among Thai medical students: A randomized three-period crossover simulation study
Introduction: In Thailand, the Emergency Severity Index (ESI) and Ministry of Public Health Emergency Department triage system (MOPH) are commonly used, whereas the Thai Rapid Initial Assessment and Grading for Emergency (TRIAGE) system has been newly proposed. Comparative evidence is limited. We compared correct triage as the primary outcome, with under-triage, over-triage, and completion time as secondary outcomes. Methods: We conducted a randomized three-period crossover simulation study at the Lampang Medical Education Center from October 2025 to January 2026. Fifth- and sixth-year medical students without recent standardized triage reinforcement classified 50 standardized patient cards per system in one of six sequences, with a one-week washout between periods. Multilevel mixed-effects models were used to estimate between-system differences, with adjustment for period, sequence, and academic year. Results: Sixty students completed all periods. No significant overall differences were detected in correct triage across TRIAGE, ESI, and MOPH (63.2%, 64.5%, and 61.8%, respectively), or in under-triage (19.6%, 20.0%, and 18.8%). Among sixth-year students, correct triage differed significantly across systems (global P = 0.004), with higher adjusted probabilities for ESI and TRIAGE than MOPH. Over-triage differed across systems and was highest with MOPH (7.0%), followed by TRIAGE (5.7%) and ESI (4.9%). Completion time was longest with TRIAGE (32.8 minutes), compared with ESI (24.3 minutes) and MOPH (23.2 minutes). Conclusion: No significant overall differences in correct or under-triage were detected, but the study was not powered to establish equivalence. MOPH showed higher over-triage, Completion time was longest with TRIAGE. Generalizability to experienced clinicians requires further study. Trial registration: Thai Clinical Trials Registry (TCTR) TCTR20260316003
- Open Access
- 1 October 2026
- Published by Elmer Press, Inc. in World Journal of Oncology
- Vol. 17 (5) , 705-716
Prediction of Residual Disease in Unresectable Head and Neck Squamous Cell Carcinoma After Concurrent Chemoradiotherapy
Background: Concurrent chemoradiotherapy (CCRT) for unresectable head and neck cancer (HNC) in advanced stages is associated with a high probability of residual disease (RD). Salvage surgery after completing CCRT often leads to severe complications, and palliative care is required if surgery is not feasible. The aim of this study was to develop a prediction model for RD based on pretreatment clinical features. Methods: This retrospective observational cohort study analyzed the medical records of patients with unresectable HNC who received CCRT at the Radiation Oncology Unit of Buddhachinaraj Phitsanulok Hospital, Thailand, between October 2019 and October 2025. Clinical features and laboratory results were collected before treatment. Tumor response was evaluated 8–12 weeks after completion of CCRT using computed tomography or magnetic resonance imaging scans according to the Response Evaluation Criteria in Solid Tumors. Multivariable logistic regression was used to identify predictors of RD. The model performance was evaluated for discrimination using the area under the receiver operating characteristic curve (AuROC) and for calibration using calibration plots. Internal validation was performed using the bootstrap resampling method. Decision curve analysis was also performed. Results: A total of 382 patients with HNC were included. After the completion of CCRT, 180 patients (47.1%) presented with RD. The final model retained primary tumor site (hypopharynx (odds ratio (OR): 3.56; 95% confidence interval (CI): 1.10–11.40) and oral cavity (OR: 3.77; 95% CI: 0.95–14.90)), maximum tumor diameter (OR: 3.37; 95% CI: 2.59–4.39), time to initiation of radiotherapy (OR: 1.01; 95% CI: 1.00–1.02), body mass index (OR: 0.97; 95% CI: 0.88–1.06), neutrophil-to-lymphocyte ratio (OR: 1.02; 95% CI: 0.94–1.10), and hemoglobin level (OR: 0.94; 95% CI: 0.79–1.11). The model demonstrated excellent discrimination, with an AuROC of 0.929 (95% CI: 0.903–0.954). At an RD probability cutoff of ≥ 47.1%, the model yielded a positive predictive value of 81.2% (95% CI: 75.1–86.4) and a negative predictive value of 89.2% (95% CI: 83.8–93.3). Conclusions: This clinical feature-based prediction model accurately predicted the probability of RD in patients with unresectable HNC. Physicians can utilize this model for pre-CCRT treatment planning to identify high-risk patients.
- 1 October 2026
- Published by Elmer Press, Inc. in World Journal of Oncology
- Vol. 17 (5) , 705-716
Open AccessPrediction of Residual Disease in Unresectable Head and Neck Squamous Cell Carcinoma After Concurrent Chemoradiotherapy
Background: Concurrent chemoradiotherapy (CCRT) for unresectable head and neck cancer (HNC) in advanced stages is associated with a high probability of residual disease (RD). Salvage surgery after completing CCRT often leads to severe complications, and palliative care is required if surgery is not feasible. The aim of this study was to develop a prediction model for RD based on pretreatment clinical features. Methods: This retrospective observational cohort study analyzed the medical records of patients with unresectable HNC who received CCRT at the Radiation Oncology Unit of Buddhachinaraj Phitsanulok Hospital, Thailand, between October 2019 and October 2025. Clinical features and laboratory results were collected before treatment. Tumor response was evaluated 8–12 weeks after completion of CCRT using computed tomography or magnetic resonance imaging scans according to the Response Evaluation Criteria in Solid Tumors. Multivariable logistic regression was used to identify predictors of RD. The model performance was evaluated for discrimination using the area under the receiver operating characteristic curve (AuROC) and for calibration using calibration plots. Internal validation was performed using the bootstrap resampling method. Decision curve analysis was also performed. Results: A total of 382 patients with HNC were included. After the completion of CCRT, 180 patients (47.1%) presented with RD. The final model retained primary tumor site (hypopharynx (odds ratio (OR): 3.56; 95% confidence interval (CI): 1.10–11.40) and oral cavity (OR: 3.77; 95% CI: 0.95–14.90)), maximum tumor diameter (OR: 3.37; 95% CI: 2.59–4.39), time to initiation of radiotherapy (OR: 1.01; 95% CI: 1.00–1.02), body mass index (OR: 0.97; 95% CI: 0.88–1.06), neutrophil-to-lymphocyte ratio (OR: 1.02; 95% CI: 0.94–1.10), and hemoglobin level (OR: 0.94; 95% CI: 0.79–1.11). The model demonstrated excellent discrimination, with an AuROC of 0.929 (95% CI: 0.903–0.954). At an RD probability cutoff of ≥ 47.1%, the model yielded a positive predictive value of 81.2% (95% CI: 75.1–86.4) and a negative predictive value of 89.2% (95% CI: 83.8–93.3). Conclusions: This clinical feature-based prediction model accurately predicted the probability of RD in patients with unresectable HNC. Physicians can utilize this model for pre-CCRT treatment planning to identify high-risk patients.
- Open Access
- 1 September 2026
- Published by Elmer Press, Inc. in Journal of Clinical Medicine Research
- Vol. 18 (9) , 612-622
Prediction Model for Detecting Active Pulmonary Tuberculosis in Patients With Head and Neck Cancer Prior to Concurrent Chemoradiotherapy
Background: Patients with cancer, particularly those with head and neck cancer (HNC), have a higher risk of developing active pulmonary tuberculosis (PTB) than the general population. Radiotherapy or concurrent chemoradiotherapy (CCRT) is a primary treatment modality for HNC. Therefore, the detection of active PTB before treatment is important. However, routine testing in all patients is not feasible. We aimed to develop a diagnostic prediction model for active PTB using routinely available pretreatment clinical and laboratory parameters in patients with HNC prior to radiotherapy. Methods: We performed a diagnostic prediction study with a retrospective, cross-sectional design using medical record reviews of all patients diagnosed with HNC who underwent radiotherapy at the Radiation Therapy Unit, Buddhachinaraj Phitsanulok Hospital, Phitsanulok, Thailand, from October 2014 to October 2025. Active PTB was defined as the initiation of anti-tuberculosis treatment with microbiological confirmation (acid-fast bacilli smear microscopy, culture, or nucleic acid amplification testing/GeneXpert) and/or chest imaging compatible with active PTB. Multivariable logistic regression was performed to derive the models. Discrimination was measured using the area under the receiver operating characteristic curve (AuROC); calibration was assessed using calibration plots, and internal validation was performed using bootstrap resampling. Decision curve analysis was used to determine clinical utility. Results: Of the 505 patients with HNC, 30 (5.94%) had active PTB. Four predictors independently associated with active PTB were body mass index (BMI) (odds ratio (OR) 0.86; 95% confidence interval (CI) 0.75–0.99), hemoglobin (OR 0.75; 95% CI 0.58–0.95), albumin (OR 0.25; 95% CI 0.12–0.53), and cancer symptom duration (months) (OR 1.49; 95% CI 1.25–1.76). The model showed excellent discrimination (AuROC 0.882; 95% CI 0.814–0.950) and good calibration (slope 1.000). At a predicted probability cutoff (≥ 5.94%), sensitivity was 90.0% (95% CI 73.5–97.9) and specificity was 82.3% (95% CI 78.6–85.6). The model may reduce the number of patients requiring confirmatory PTB testing, missing only three of 505 patients (0.6%) overall. Conclusions: In patients with HNC undergoing pretreatment evaluation, a simple four-variable model (BMI, hemoglobin level, albumin concentration, and cancer symptom duration) can estimate the probability of active PTB.
- 1 September 2026
- Published by Elmer Press, Inc. in Journal of Clinical Medicine Research
- Vol. 18 (9) , 612-622
Open AccessPrediction Model for Detecting Active Pulmonary Tuberculosis in Patients With Head and Neck Cancer Prior to Concurrent Chemoradiotherapy
Background: Patients with cancer, particularly those with head and neck cancer (HNC), have a higher risk of developing active pulmonary tuberculosis (PTB) than the general population. Radiotherapy or concurrent chemoradiotherapy (CCRT) is a primary treatment modality for HNC. Therefore, the detection of active PTB before treatment is important. However, routine testing in all patients is not feasible. We aimed to develop a diagnostic prediction model for active PTB using routinely available pretreatment clinical and laboratory parameters in patients with HNC prior to radiotherapy. Methods: We performed a diagnostic prediction study with a retrospective, cross-sectional design using medical record reviews of all patients diagnosed with HNC who underwent radiotherapy at the Radiation Therapy Unit, Buddhachinaraj Phitsanulok Hospital, Phitsanulok, Thailand, from October 2014 to October 2025. Active PTB was defined as the initiation of anti-tuberculosis treatment with microbiological confirmation (acid-fast bacilli smear microscopy, culture, or nucleic acid amplification testing/GeneXpert) and/or chest imaging compatible with active PTB. Multivariable logistic regression was performed to derive the models. Discrimination was measured using the area under the receiver operating characteristic curve (AuROC); calibration was assessed using calibration plots, and internal validation was performed using bootstrap resampling. Decision curve analysis was used to determine clinical utility. Results: Of the 505 patients with HNC, 30 (5.94%) had active PTB. Four predictors independently associated with active PTB were body mass index (BMI) (odds ratio (OR) 0.86; 95% confidence interval (CI) 0.75–0.99), hemoglobin (OR 0.75; 95% CI 0.58–0.95), albumin (OR 0.25; 95% CI 0.12–0.53), and cancer symptom duration (months) (OR 1.49; 95% CI 1.25–1.76). The model showed excellent discrimination (AuROC 0.882; 95% CI 0.814–0.950) and good calibration (slope 1.000). At a predicted probability cutoff (≥ 5.94%), sensitivity was 90.0% (95% CI 73.5–97.9) and specificity was 82.3% (95% CI 78.6–85.6). The model may reduce the number of patients requiring confirmatory PTB testing, missing only three of 505 patients (0.6%) overall. Conclusions: In patients with HNC undergoing pretreatment evaluation, a simple four-variable model (BMI, hemoglobin level, albumin concentration, and cancer symptom duration) can estimate the probability of active PTB.
- Open Access
- 1 January 2026
- Published by Elmer Press, Inc. in Journal of Clinical Medicine Research
- Vol. 18 (1) , 50-61
Predicting Breast Imaging-Reporting and Data System Classification of Palpable Breast Masses Using Ultrasound to Prioritize Mammography Queues
Background: Breast cancer is the leading cause of cancer death in women worldwide. Breast imaging, usually mammography and/or ultrasound, is classified using the Breast Imaging-Reporting and Data System (BI-RADS). At Lampang Hospital, mammography delays of up to 5 months postpone diagnosis in 40% of breast cancer cases. An urgent queue for palpable breast masses was introduced, but nearly half were benign, leading to inefficient prioritization. This study aimed to develop a two-step model based on high-risk ultrasound features and compare it with reference BI-RADS classifications. Methods: This diagnostic prediction study collected retrospective data from Lampang Hospital between January 2021 and December 2023. Ultrasound images of 390 patients were independently reviewed by radiologists blinded to the reference BI-RADS classification. Stepwise multivariable risk difference regression analysis was applied to identify predictive characteristics from seven predefined ultrasound findings. Results: Three predictive characteristics were identified: shape, margin, and echo pattern. The two-step model showed excellent discrimination, with an area under the receiver operating characteristic curve (AuROC) of 0.9801 (95% CI, 0.9696–0.9907) in step 1 and 0.9623 (95% CI, 0.9411–0.9835) in step 2. Internal validation with 200 bootstrap cycles confirmed minimal optimism. Using prevalence-based cut points, the model achieved 88.5% accuracy, with 6.7% underestimation in BI-RADS 4–5 (predicted as 3) and overestimation not exceeding 3% in any category. Conclusions: A two-step ultrasound-based model using shape, margin, and echo pattern demonstrated excellent discrimination as well as high accuracy, with slightly increased underestimation and minimal overestimation. This re-scheduling strategy optimizes mammography queue prioritization, but external validation is required before clinical implementation.
- 1 January 2026
- Published by Elmer Press, Inc. in Journal of Clinical Medicine Research
- Vol. 18 (1) , 50-61
Open AccessPredicting Breast Imaging-Reporting and Data System Classification of Palpable Breast Masses Using Ultrasound to Prioritize Mammography Queues
Background: Breast cancer is the leading cause of cancer death in women worldwide. Breast imaging, usually mammography and/or ultrasound, is classified using the Breast Imaging-Reporting and Data System (BI-RADS). At Lampang Hospital, mammography delays of up to 5 months postpone diagnosis in 40% of breast cancer cases. An urgent queue for palpable breast masses was introduced, but nearly half were benign, leading to inefficient prioritization. This study aimed to develop a two-step model based on high-risk ultrasound features and compare it with reference BI-RADS classifications. Methods: This diagnostic prediction study collected retrospective data from Lampang Hospital between January 2021 and December 2023. Ultrasound images of 390 patients were independently reviewed by radiologists blinded to the reference BI-RADS classification. Stepwise multivariable risk difference regression analysis was applied to identify predictive characteristics from seven predefined ultrasound findings. Results: Three predictive characteristics were identified: shape, margin, and echo pattern. The two-step model showed excellent discrimination, with an area under the receiver operating characteristic curve (AuROC) of 0.9801 (95% CI, 0.9696–0.9907) in step 1 and 0.9623 (95% CI, 0.9411–0.9835) in step 2. Internal validation with 200 bootstrap cycles confirmed minimal optimism. Using prevalence-based cut points, the model achieved 88.5% accuracy, with 6.7% underestimation in BI-RADS 4–5 (predicted as 3) and overestimation not exceeding 3% in any category. Conclusions: A two-step ultrasound-based model using shape, margin, and echo pattern demonstrated excellent discrimination as well as high accuracy, with slightly increased underestimation and minimal overestimation. This re-scheduling strategy optimizes mammography queue prioritization, but external validation is required before clinical implementation.
- Open Access
- 1 December 2025
- Published by Elmer Press, Inc. in Journal of Neurology Research
- Vol. 15 (4) , 172-181
Mortality Following Intracerebral Hemorrhage After Intravenous Alteplase in Acute Ischemic Stroke: A Decision Tree-Based Classification Approach
- 1 December 2025
- Published by Elmer Press, Inc. in Journal of Neurology Research
- Vol. 15 (4) , 172-181
Open AccessMortality Following Intracerebral Hemorrhage After Intravenous Alteplase in Acute Ischemic Stroke: A Decision Tree-Based Classification Approach
- Open Access
- 1 December 2025
- Published by Elmer Press, Inc. in Journal of Clinical Medicine Research
- Vol. 17 (12) , 676-687
Machine Learning-Based Model to Classify Emergency Severity Index Levels 1-3 in Febrile Patients With Tachycardia: Thailand Triage Prediction System
Background: Febrile patients with tachycardia present diverse profiles that complicate triage. Although the Emergency Severity Index (ESI) is widely used in Thailand, inter-rater variability limits consistency. Machine learning (ML) may enhance reliability using routinely collected triage data. The objectives were to develop and evaluate ML models predicting ESI levels 1-3 in febrile tachycardic adults and identify the best model for clinical use. Methods: This diagnostic prediction study analyzed adults with fever (≥ 37.6 °C) and pulse rate > 100 beats per minute in the triage area of Lampang Hospital, Thailand, during June - August 2024. Patients with complete data were included, whereas referrals and expert-disagreement cases were excluded. Expert-assigned ESI levels were the outcome. Thirteen routinely collected triage variables were evaluated as candidate predictors. The dataset (n = 500) was randomly split 80:20 into development and testing sets. Random forest, extreme gradient boosting (XGBoost), and gradient boosting machine models were developed using five-fold cross-validation with class-weighting for imbalance correction. Performance was assessed using area under the receiver operating characteristic curve (AuROC), calibration, and confusion matrices, with attention to clinically relevant misclassification. Results: XGBoost demonstrated the best discrimination with AuROC values of 1.00 (confidence interval (CI): 0.99 - 1.00), 0.94 (CI: 0.89 - 0.98), and 0.97 (CI: 0.93 - 1.00) for ESI levels 1-3 in the test set. Calibration showed the lowest Brier scores, and misclassification was minimal, supporting strong predictive consistency across categories. Conclusions: XGBoost was selected for integration into the Smart ER system as the Thailand Triage Prediction System (TTPS), providing real-time prediction to enhance triage accuracy, support decision-making, and improve workflow.
- 1 December 2025
- Published by Elmer Press, Inc. in Journal of Clinical Medicine Research
- Vol. 17 (12) , 676-687
Open AccessMachine Learning-Based Model to Classify Emergency Severity Index Levels 1-3 in Febrile Patients With Tachycardia: Thailand Triage Prediction System
Background: Febrile patients with tachycardia present diverse profiles that complicate triage. Although the Emergency Severity Index (ESI) is widely used in Thailand, inter-rater variability limits consistency. Machine learning (ML) may enhance reliability using routinely collected triage data. The objectives were to develop and evaluate ML models predicting ESI levels 1-3 in febrile tachycardic adults and identify the best model for clinical use. Methods: This diagnostic prediction study analyzed adults with fever (≥ 37.6 °C) and pulse rate > 100 beats per minute in the triage area of Lampang Hospital, Thailand, during June - August 2024. Patients with complete data were included, whereas referrals and expert-disagreement cases were excluded. Expert-assigned ESI levels were the outcome. Thirteen routinely collected triage variables were evaluated as candidate predictors. The dataset (n = 500) was randomly split 80:20 into development and testing sets. Random forest, extreme gradient boosting (XGBoost), and gradient boosting machine models were developed using five-fold cross-validation with class-weighting for imbalance correction. Performance was assessed using area under the receiver operating characteristic curve (AuROC), calibration, and confusion matrices, with attention to clinically relevant misclassification. Results: XGBoost demonstrated the best discrimination with AuROC values of 1.00 (confidence interval (CI): 0.99 - 1.00), 0.94 (CI: 0.89 - 0.98), and 0.97 (CI: 0.93 - 1.00) for ESI levels 1-3 in the test set. Calibration showed the lowest Brier scores, and misclassification was minimal, supporting strong predictive consistency across categories. Conclusions: XGBoost was selected for integration into the Smart ER system as the Thailand Triage Prediction System (TTPS), providing real-time prediction to enhance triage accuracy, support decision-making, and improve workflow.